These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2697894)

  • 1. Clinical value of deconvolution analysis in radionuclide renal study.
    Nakagawa T; Maeda H; Terada N; Ono M; Ohi M; Ito T; Takeda K; Tagami T; Matsushita T
    Radiat Med; 1989; 7(5):236-42. PubMed ID: 2697894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of renograms with simultaneous injection of 99mTc-DTPA and 131I-OIH--estimation of GFR, ERPF and retention function of individual kidney].
    Maeda M; Hasegawa R; Tanaka S; Yoshida H
    Kaku Igaku; 1985 Sep; 22(9):1341-52. PubMed ID: 3910897
    [No Abstract]   [Full Text] [Related]  

  • 3. Aluminemic disturbance of technetium-99m DTPA renal function measurement.
    Specht HD; Belsey R; Hanada J
    J Nucl Med; 1987 Mar; 28(3):383-6. PubMed ID: 3546628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal arteriovenous transit times of technetium-radiolabeled chelates.
    Conrad GR; Wesolowski CA; Berbaum KS; Jensen KC; Kirchner PT
    J Nucl Med; 1987 Jul; 28(7):1134-43. PubMed ID: 3298571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physiologic approach to renal scintigraphy. Application to evaluation of hypertension.
    Turpin S; Lambert R; Milot A; Taillefer R; Leveille J; Lefebvre B
    Clin Nucl Med; 1995 Mar; 20(3):206-10. PubMed ID: 7750211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Captopril renography in two kidney and one kidney Goldblatt hypertension in dogs.
    Nally JV; Clarke HS; Gupta BK; Gross ML; Low LR; Potvin WJ; Windham JP; Grecos GP
    J Nucl Med; 1987 Jul; 28(7):1171-9. PubMed ID: 3298573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a simple isotopic technique for the measurement of global and separated renal function.
    Chachati A; Meyers A; Rigo P; Godon JP
    Uremia Invest; 1985-1986; 9(2):177-9. PubMed ID: 3915921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of renal artery reconstruction on kidney perfusion and tubular function measured by new radionuclide techniques.
    Torsello G; Szabò Z; Sandmann W; Vosberg H
    J Cardiovasc Surg (Torino); 1988; 29(3):296-9. PubMed ID: 3288640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alteration of split renal function during captopril treatment: diagnostic significance in renovascular hypertension].
    Aburano T; Takayama T; Nakajima K; Tonami N; Hisada K; Yasuhara S; Miyamori I; Takeda R
    Kaku Igaku; 1987 Jul; 24(7):975-82. PubMed ID: 3323583
    [No Abstract]   [Full Text] [Related]  

  • 10. Validity of the mean parenchymal transit time as a screening test for the detection of functional renal artery stenosis in hypertensive patients.
    al-Nahhas A; Marcus AJ; Bomanji J; Nimmon CC; Dacie JE; Britton KE
    Nucl Med Commun; 1989 Nov; 10(11):807-15. PubMed ID: 2689942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of methods for calculating glomerular filtration rate: technetium-99m-DTPA scintigraphic analysis, protein-free and whole-plasma clearance of technetium-99m-DTPA and iodine-125-iothalamate clearance.
    Goates JJ; Morton KA; Whooten WW; Greenberg HE; Datz FL; Handy JE; Scuderi AJ; Haakenstad AO; Lynch RE
    J Nucl Med; 1990 Apr; 31(4):424-9. PubMed ID: 2182797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Simultaneous determination of the GRF and the ERPF (effective renal plasma flow) using a single blood sample in the slope clearance with 99mTc-DTPA and I 131-hippurate].
    Schumann L; Esther G; Wüstenberg PW; Hortian B
    Z Urol Nephrol; 1990 Jul; 83(7):391-7. PubMed ID: 2238881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal effects of captopril in hypertension with renal artery stenosis. Comparison between Tc-99m-DTPA scintigraphy and clearance method].
    Chaignon M; Coutant V; Akerman M; Tainturier C; Lucsko M; Guedon J
    Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1205-9. PubMed ID: 2510650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The radionuclide diagnosis of vasorenal hypertension using an angiotensin-converting enzyme inhibitor].
    Vozianov AF; Shcherbak AIu; Prishchepa PP; Zubko VI; Guts RV; Sabadash AS
    Lik Sprava; 1994; (9-12):64-8. PubMed ID: 7604589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal functional response to captopril during diuretic therapy.
    Lee HB; Blaufox MD
    J Nucl Med; 1992 May; 33(5):739-43. PubMed ID: 1569484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Captopril scintigraphy in the diagnosis of renovascular hypertension.
    Sfakianakis GN; Jaffe DJ; Bourgoignie JJ
    Kidney Int Suppl; 1988 Sep; 25():S142-4. PubMed ID: 3054230
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors affecting the Gates' measurement of glomerular filtration rate.
    Awdeh M; Kouris K; Hassan IM; Abdel-Dayem HM
    Am J Physiol Imaging; 1990; 5(1):36-41. PubMed ID: 2196915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional radionuclide imaging of renal mean transit time and glomerular filtration rate.
    Fleming JS
    Nucl Med Commun; 1988 Feb; 9(2):85-96. PubMed ID: 3290749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and imaging studies.
    Dubovsky EV
    Clin Nucl Med; 1981 Oct; 6(10S):P46-54. PubMed ID: 6271442
    [No Abstract]   [Full Text] [Related]  

  • 20. Afferent-efferent vessel dysfunction appears to be a specific characteristic of a large subset of patients with essential hypertension.
    Clorius JH; Schottler T; Haufe S; Zuna I; Reinbold F; van Kaick G
    Am J Hypertens; 2000 Apr; 13(4 Pt 1):332-9. PubMed ID: 10821332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.